Literature DB >> 18777189

Radiologic findings following Y90 radioembolization for primary liver malignancies.

Saad M Ibrahim1, Paul Nikolaidis, Frank H Miller, Robert J Lewandowski, Robert K Ryu, Kent T Sato, Sean Senthilnathan, Ahsun Riaz, Laura Kulik, Mary F Mulcahy, Reed A Omary, Riad Salem.   

Abstract

A therapy gaining rapid clinical adoption involves radioembolization with the use of Yttrium-90 (90Y) microspheres. The 20-60 microm-sized microspheres are injected trans-arterially and flow to hepatic tumors given their preferential blood supply from the hepatic artery. Once they lodge in the arterioles, they impart a very intense local radiotherapeutic effect. Given the combined radiation and embolic effect, the imaging findings imparted by this mode of action differ significantly from other treatments. This work represents a comprehensive review of the imaging findings following radioembolization in patients with primary liver tumors. The report discusses imaging response, benign secondary effects, and complications. This should help educate the radiologist on imaging findings that should be expected following radioembolization and therefore aid in the proper image interpretation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18777189     DOI: 10.1007/s00261-008-9454-y

Source DB:  PubMed          Journal:  Abdom Imaging        ISSN: 0942-8925


  22 in total

Review 1.  Radioembolization for primary and metastatic liver cancer.

Authors:  Khairuddin Memon; Robert J Lewandowski; Laura Kulik; Ahsun Riaz; Mary F Mulcahy; Riad Salem
Journal:  Semin Radiat Oncol       Date:  2011-10       Impact factor: 5.934

2.  Radioembolization for hepatocellular carcinoma complicated by biliary stricture.

Authors:  Jeet Minocha; Robert J Lewandowski
Journal:  Semin Intervent Radiol       Date:  2011-06       Impact factor: 1.513

3.  Treatment planning and volumetric response assessment for Yttrium-90 radioembolization: semiautomated determination of liver volume and volume of tumor necrosis in patients with hepatic malignancy.

Authors:  Wayne L Monsky; Armando S Garza; Isaac Kim; Shaun Loh; Tzu-Chun Lin; Chin-Shang Li; Jerron Fisher; Parmbir Sandhu; Vishal Sidhar; Abhijit J Chaudhari; Frank Lin; Larry-Stuart Deutsch; Ramsey D Badawi
Journal:  Cardiovasc Intervent Radiol       Date:  2010-08-04       Impact factor: 2.740

4.  Complete response of hepatocellular carcinoma with sorafenib and Y radioembolization.

Authors:  P K Chaudhury; M Hassanain; J M Bouteaud; T Alcindor; C G Nudo; D Valenti; T Cabrera; P Kavan; I Feteih; P Metrakos
Journal:  Curr Oncol       Date:  2010-10       Impact factor: 3.677

Review 5.  Assessing locoregional treatment response to Hepatocellular Carcinoma: comparison of hepatobiliary contrast agents to extracellular contrast agents.

Authors:  Anum Aslam; Amita Kamath; Bradley Spieler; Mark Maschiocchi; Carl F Sabottke; Victoria Chernyak; Sara C Lewis
Journal:  Abdom Radiol (NY)       Date:  2021-04-15

Review 6.  Artificial intelligence in assessment of hepatocellular carcinoma treatment response.

Authors:  Bradley Spieler; Carl Sabottke; Ahmed W Moawad; Ahmed M Gabr; Mustafa R Bashir; Richard Kinh Gian Do; Vahid Yaghmai; Radu Rozenberg; Marielia Gerena; Joseph Yacoub; Khaled M Elsayes
Journal:  Abdom Radiol (NY)       Date:  2021-03-31

Review 7.  Treatment response assessment following transarterial radioembolization for hepatocellular carcinoma.

Authors:  Zersenay Alem; Timothy E Murray; Csilla Egri; John Chung; David Liu; Khaled M Elsayes; Silvia D Chang; Alison Harris
Journal:  Abdom Radiol (NY)       Date:  2021-04-28

Review 8.  Locoregional therapies for hepatocellular carcinoma and the new LI-RADS treatment response algorithm.

Authors:  Ania Kielar; Kathryn J Fowler; Sara Lewis; Vahid Yaghmai; Frank H Miller; Hooman Yarmohammadi; Charles Kim; Victoria Chernyak; Takeshi Yokoo; Jeffrey Meyer; Isabel Newton; Richard K Do
Journal:  Abdom Radiol (NY)       Date:  2018-01

9.  Clinical outcomes of Y90 radioembolization for recurrent hepatocellular carcinoma following curative resection.

Authors:  Rehan Ali; Ahsun Riaz; Ahmed Gabr; Nadine Abouchaleh; Ronald Mora; Ali Al Asadi; Juan Carlos Caicedo; Michael Abecassis; Nitin Katariya; Haripriya Maddur; Laura Kulik; Robert J Lewandowski; Riad Salem
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-08-15       Impact factor: 9.236

10.  Research reporting standards for radioembolization of hepatic malignancies.

Authors:  Riad Salem; Robert J Lewandowski; Vanessa L Gates; Charles W Nutting; Ravi Murthy; Steven C Rose; Michael C Soulen; Jean-Francois H Geschwind; Laura Kulik; Yun Hwan Kim; Carlo Spreafico; Marco Maccauro; Lourens Bester; Daniel B Brown; Robert K W Ryu; Daniel Y Sze; William S Rilling; Kent T Sato; Bruno Sangro; Jose Ignacio Bilbao; Tobias F Jakobs; Samer Ezziddin; Suyash Kulkarni; Aniruddha Kulkarni; David M Liu; David Valenti; Philip Hilgard; Gerald Antoch; Stefan P Muller; Hamad Alsuhaibani; Mary F Mulcahy; Marta Burrel; Maria Isabel Real; Stewart Spies; Abdulredha A Esmail; Jean-Luc Raoul; Etienne Garin; Mathew S Johnson; Al B Benson; Ricky A Sharma; Harpreet Wasan; Bieke Lambert; Khairuddin Memon; Andrew S Kennedy; Ahsun Riaz
Journal:  J Vasc Interv Radiol       Date:  2011-03       Impact factor: 3.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.